Literature DB >> 33548031

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Yana Geng1, Klaas Nico Faber2,3, Vincent E de Meijer4, Hans Blokzijl2, Han Moshage2,3.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid accumulation in the liver which is not due to alcohol use, has emerged as one of the major health problems around the world. The dysregulated lipid metabolism creates a lipotoxic environment which promotes the development of NAFLD, especially the progression from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH). PURPOSEAND AIM: This review focuses on the mechanisms of lipid accumulation in the liver, with an emphasis on the metabolic fate of free fatty acids (FFAs) in NAFLD and presents an update on the relevant cellular processes/mechanisms that are involved in lipotoxicity. The changes in the levels of various lipid species that result from the imbalance between lipolysis/lipid uptake/lipogenesis and lipid oxidation/secretion can cause organellar dysfunction, e.g. ER stress, mitochondrial dysfunction, lysosomal dysfunction, JNK activation, secretion of extracellular vesicles (EVs) and aggravate (or be exacerbated by) hypoxia which ultimately lead to cell death. The aim of this review is to provide an overview of how abnormal lipid metabolism leads to lipotoxicity and the cellular mechanisms of lipotoxicity in the context of NAFLD.

Entities:  

Keywords:  Cell death; ER stress; Free fatty acids; JNK; Lipid metabolism; Lipotoxicity; MAFLD; Mitochondrial dysfunction; NAFLD; NASH

Year:  2021        PMID: 33548031     DOI: 10.1007/s12072-020-10121-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  106 in total

1.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

2.  Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?

Authors:  Christopher D Byrne; Gianluca Perseghin
Journal:  J Hepatol       Date:  2017-12-10       Impact factor: 25.083

Review 3.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

4.  Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.

Authors:  George Cholankeril; Robert J Wong; Menghan Hu; Ryan B Perumpail; Eric R Yoo; Puneet Puri; Zobair M Younossi; Stephen A Harrison; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2017-07-25       Impact factor: 3.199

Review 5.  Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Juan Pablo Arab; Marco Arrese; Michael Trauner
Journal:  Annu Rev Pathol       Date:  2018-01-24       Impact factor: 23.472

Review 6.  Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.

Authors:  Sonja Lang; Bernd Schnabl
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

Review 7.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.

Authors:  Zobair M Younossi; Giulio Marchesini; Helena Pinto-Cortez; Salvatore Petta
Journal:  Transplantation       Date:  2019-01       Impact factor: 4.939

Review 8.  Mechanisms of NAFLD development and therapeutic strategies.

Authors:  Scott L Friedman; Brent A Neuschwander-Tetri; Mary Rinella; Arun J Sanyal
Journal:  Nat Med       Date:  2018-07-02       Impact factor: 53.440

9.  Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.

Authors:  Eline H van den Berg; Marzyeh Amini; Tim C M A Schreuder; Robin P F Dullaart; Klaas Nico Faber; Behrooz Z Alizadeh; Hans Blokzijl
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

Review 10.  Dietary lipids, gut microbiota and lipid metabolism.

Authors:  Marc Schoeler; Robert Caesar
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

View more
  19 in total

1.  Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).

Authors:  Giada Sebastiani; Keyur Patel; Vlad Ratziu; Jordan J Feld; Brent A Neuschwander-Tetri; Massimo Pinzani; Salvatore Petta; Annalisa Berzigotti; Peter Metrakos; Naglaa Shoukry; Elizabeth M Brunt; An Tang; Jeremy F Cobbold; Jean-Marie Ekoe; Karen Seto; Peter Ghali; Stéphanie Chevalier; Quentin M Anstee; Heather Watson; Harpreet Bajaj; James Stone; Mark G Swain; Alnoor Ramji
Journal:  Can Liver J       Date:  2022-02-04

Review 2.  Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Authors:  Raja Gopal Reddy Mooli; Sadeesh K Ramakrishnan
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

Review 3.  NAFLD: Mechanisms, Treatments, and Biomarkers.

Authors:  Fatiha Nassir
Journal:  Biomolecules       Date:  2022-06-13

4.  Animal Evidence for Synergistic Induction of Hepatic Injury by Dietary Fat and Alcohol Consumption and Its Potential Mechanisms.

Authors:  Hyeong-Geug Kim; Jing-Hua Wang; Hyo-Seon Kim; Jin-Seok Lee; Hwi-Jin Im; Sung-Bae Lee; Dong-Soo Lee; Gang-Min Hur; Chang-Gue Son
Journal:  J Pers Med       Date:  2021-04-08

Review 5.  Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions.

Authors:  Maria Notarnicola; Alberto Ruben Osella; Maria Gabriella Caruso; Pasqua Letizia Pesole; Antonio Lippolis; Valeria Tutino; Caterina Bonfiglio; Valentina De Nunzio; Maria Principia Scavo; Antonella Mirizzi; Isabella Franco; Tamara Lippolis; Rosalba D'Alessandro; Maria Grazia Refolo; Caterina Messa
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

6.  The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease.

Authors:  Xiaoxiao Ge; Tao Sun; Yanmei Zhang; Yongqing Li; Peng Gao; Dantong Zhang; Bingyang Zhang; Peijun Wang; Wanshan Ma; Sumei Lu
Journal:  Nutr Metab (Lond)       Date:  2022-01-12       Impact factor: 4.169

7.  Heat-Killed Enterococcus faecalis EF-2001 Attenuate Lipid Accumulation in Diet-Induced Obese (DIO) Mice by Activating AMPK Signaling in Liver.

Authors:  Meiqi Fan; Young-Jin Choi; Nishala Erandi Wedamulla; Yujiao Tang; Kwon Il Han; Ji-Young Hwang; Eun-Kyung Kim
Journal:  Foods       Date:  2022-02-16

Review 8.  Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Seonghwan Hwang; Hwayoung Yun; Sungwon Moon; Ye Eun Cho; Bin Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-11       Impact factor: 5.555

9.  Palm Oil-Rich Diet Affects Murine Liver Proteome and S-Palmitoylome.

Authors:  Ewelina Ziemlińska; Justyna Sobocińska; Anna Świątkowska; Aneta Hromada-Judycka; Gabriela Traczyk; Agata Malinowska; Bianka Świderska; Anna Mietelska-Porowska; Anna Ciesielska; Katarzyna Kwiatkowska
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

Review 10.  Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis.

Authors:  Virender Kumar; Xiaofei Xin; Jingyi Ma; Chalet Tan; Natalia Osna; Ram I Mahato
Journal:  Adv Drug Deliv Rev       Date:  2021-07-24       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.